Can Europe's Approval And Value Reviews Work More In Concert? It's A Timesaver That Might Be A Long Time Coming

In recent years, European drug approval agencies and health technology assessment authorities had little interchange, reflecting mutual disregard at best, and mutual recrimination at worst, European Medicines Agency Senior Medical Officer Hans-Georg Eichler observed.